Cardiotrophin-1 regulatory update
FDA and the European Commission granted Orphan Drug designation for Digna's cardiotrophin-1 to treat acute liver failure. The recombinant human CT-1 is in Phase I testing to treat ischemic and reperfusion injuries associated with liver...